Please login to the form below

Not currently logged in

Dr Bug mobile game introduces kids to antibiotics, bacteria and viruses

The not-for-profit app is a collaboration between Oxford PharmaGenesis and Global Initiative


HealthScience communications consultancy Oxford PharmaGenesis has partnered up with digital developer Global Initiative to create an educational, not-for-profit mobile app.

The free Android game - called Dr Bug: Microbe Mayhem - is aimed at children aged seven to 12 and takes children on a journey learning about bacteria, viruses and the use of antibiotics.

The app that was launched at the Oxfordshire Science Festival this month will “stimulate conversations within families about healthcare choices in a way that is enjoyable”, said Dr Dane Comerford, director of the science festival.

“We are delighted that the Oxfordshire Science Festival was the launch pad for the app,” he adds.

The prototype was user-tested by children in years two to six at Aston and Cote Church of England Primary School and Gareth Nixon, Global Initiative’s managing director, said: “The most thrilling thing for us is to be able to broaden minds, and what better place to start than with children?”

“Through our work in digital health, we’ve become more aware of, and frustrated by, the overuse and misuse of antibiotics; the more we can educate about appropriate use at a young age, the better chance we have of averting an antibiotic crisis."

Article by
Gemma Jones

29th June 2017

From: Marketing



Featured jobs

Subscribe to our email news alerts


Add my company
Cello Health

Cello Health’s mission is to help our clients unlock the potential that exists with their assets, brands and organisations in...

Latest intelligence

How to get rep buy-in for multi-channel
How do you manage a team who may be resistant to change?...
Blog: Digital therapeutics: within our reach?
Digital therapeutics is a hot topic right now. By using digital technology to manage, treat or even prevent chronic conditions, digital therapeutics is promising to revolutionise healthcare. But is this...
figure 1
The valuable brand
Creating value beyond the pill is both possible and increasingly necessary...